Valeant Pharmaceuticals International News

Kurse + Charts + Realtime	News + Analysen	Fundamental	Unternehmen	zugeh. Wertpapiere	Aktion
Kurs + Chart	Chart (gross)	News + Adhoc	Bilanz/GuV	Termine	Strukturierte Produkte	Portfolio
Times + Sales	Chartvergleich	Analysen	Schätzungen	Profil		Watchlist
Börsenplätze	Realtime Push	Kursziele	Dividende/GV
Historisch			Analysen

Kurse + Charts + Realtime

News + Analysen

Fundamental

Unternehmen

zugeh. Wertpapiere

Aktion

Kurs + Chart

Chart (gross)

News + Adhoc

Bilanz/GuV

Termine

Strukturierte Produkte

Portfolio

Times + Sales

Chartvergleich

Analysen

Schätzungen

Profil

Watchlist

Börsenplätze

Realtime Push

Kursziele

Dividende/GV

Historisch

Analysen

29.09.17	Farewell Message to Canadians by Governor General David Johnston (PR Newswire)
29.09.17	Valeant Closes Sale Of INova Pharma To Pacific Equity Partners And Carlyle Group (RTTNews)
29.09.17	Valeant Pharmaceuticals Completes Sale Of iNova Pharmaceuticals To Pacific Equity Partners And The Carlyle Group (PR Newswire)
29.09.17	Valeant Pharmaceuticals Completes Sale Of iNova Pharmaceuticals To Pacific Equity Partners And The Carlyle Group (PR Newswire)
28.09.17	Ouverture du 76e Congrès annuel de la FQM - Le premier ministre Couillard répond positivement aux demandes de la FQM (PR Newswire)
28.09.17	Avis aux médias - Le programme des Ordinateurs pour les écoles soulignera un jalon clé de son histoire (PR Newswire)
28.09.17	Pembina Pipeline Corporation Announces Phase V Pipeline Expansion Update (PR Newswire)
28.09.17	Valeant Pharmaceuticals Provides Update On Canadian Regulatory Filing About Future Financing Plans (PR Newswire)
28.09.17	Valeant Pharmaceuticals Provides Update On Canadian Regulatory Filing About Future Financing Plans (PR Newswire)
27.09.17	Montréal's Bronfman family to receive the EY Entrepreneur Of The Year™ Family Business Award of Excellence (PR Newswire)
27.09.17	CI Financial Corp. completes debenture offering (PR Newswire)
27.09.17	Valeant to Participate at the Deutsche Bank 25th Annual Leveraged Finance Conference (PR Newswire)
27.09.17	Valeant to Participate at the Deutsche Bank 25th Annual Leveraged Finance Conference (PR Newswire)
26.09.17	Winner of the 2017 Grace-Pépin Access to Information Award (PR Newswire)
25.09.17	Diane Giard to speak at the CIBC Eastern Institutional Investor Conference (PR Newswire)
22.09.17	CNW Telbec - Au fil de la journée média - les 23 et 24 septembre 2017 (PR Newswire)
21.09.17	UNICEF intensifies efforts after second earthquake in Mexico (PR Newswire)
19.09.17	IDT Corporation to Report Fourth Quarter and Full Fiscal Year 2017 Results (PR Newswire)
18.09.17	Valeant To Participate At The Cantor Fitzgerald Global Healthcare Conference (PR Newswire)
15.09.17	Valeant Commits $200,000 to Support Hurricane Relief Efforts (PR Newswire)
12.09.17	Del Mar Recovery Solutions Announces Corporate Rebranding and Strategic Initiatives to Support Growth Plan (PR Newswire)
06.09.17	Valeant To Participate At The Morgan Stanley Global Healthcare Conference (PR Newswire)
06.09.17	MDXG Revises Q3 Outlook, Two Down, One To Go For BLPH, TECH Opens Wallet (RTTNews)
05.09.17	Ortho Dermatologics Submits New Drug Application To The U.S. Food And Drug Administration For Psoriasis Treatment IDP-118 (PR Newswire)
01.09.17	Technical Snapshots for these Drug Delivery Stocks -- Delcath Systems, Valeant Pharma, PetMed Express, and Adamis Pharma (PR Newswire)
17.08.17	ABIO To Report Data In Q1; IOVA Fired Up, PMD In Iowa, VRX All Cleared (RTTNews)
17.08.17	Valeant Receives FDA Confirmation Of VAI Inspection For Tampa Facility (RTTNews)
16.08.17	Valeant Receives FDA Confirmation Of Voluntary Action Indicated (VAI) Inspection Classification For Tampa Facility (PR Newswire)
10.08.17	Paulson & Co., Inc. Reiterates Confidence In Valeant Strategy (PR Newswire)
08.08.17	MÄRKTE USA/Rekordserie im Dow-Jones geht zu Ende (Dow Jones)
08.08.17	Valeant Cuts Revenue Outlook (RTTNews)
08.08.17	MÄRKTE USA/Konjunkturskepsis beendet Dow-Gewinnstrecke (Dow Jones)
08.08.17	Valeant Announces Second-Quarter 2017 Results (PR Newswire)
07.08.17	Valeant Pharmaceuticals Receives Complete Response Letter from the FDA for Latanoprostene Bunod Ophthalmic Solution, 0.024% NDA (PR Newswire)
31.07.17	Biotech Stocks Facing FDA Decision In August (RTTNews)
27.07.17	Valeant Announces U.S. Launch of SILIQ™ (brodalumab) Injection (PR Newswire)
27.07.17	Pharming Reports on Financial Results for the First Half of 2017 (PR Newswire)
24.07.17	Daily Technical Summary Reports on Healthcare Stocks -- Valeant Pharma, Palatin Technologies, AMAG Pharma, and IDEXX Labs (PR Newswire)
17.07.17	MÄRKTE USA/Flauer Handel vor Quartalsberichten (Dow Jones)
17.07.17	MÄRKTE USA/Börsen kaum verändert - Zurückhaltung vor Bilanzsaison (Dow Jones)
17.07.17	MÄRKTE USA/Wall Street kaum verändert erwartet (Dow Jones)
17.07.17	Valeant Pharma Announces Sale Of Obagi Medical Products Business - Quick Facts (RTTNews)
17.07.17	Valeant Agrees To Sell Obagi Medical Products Business (PR Newswire)
13.07.17	Valeant Announces Redemption Of Remaining Approximately $500 Million Aggregate Principal Amount Of Its Outstanding 6.75% Senior Notes Due 2018 (PR Newswire)
10.07.17	Valeant Announces Q2 2017 Financial Results Date And Conference Call Details (PR Newswire)
10.07.17	Valeant Pays Down $811 Million of Senior Secured Term Loans (PR Newswire)
29.06.17	Sanpower Group Completes the Acquisition of Dendreon from Valeant (PR Newswire)
29.06.17	Valeant Pharma Affiliate Completes Sale Of Dendreon - Quick Facts (RTTNews)
29.06.17	Valeant Pharmaceuticals Completes Sale Of Dendreon To Sanpower Group (PR Newswire)
20.06.17	Valeant Appoints Arthur J. Shannon As Senior Vice President, Head Of Investor Relations And Communications (PR Newswire)

Aktien Top/Flop

SMI
SPI
SLI
SMIM
DAX
ESTOXX
Dow Jones
S&P 500
NASDAQ 100
Nikkei 225

Portfolioname Watchlistname
Portfolio
Name
Typ
Valor / ISIN
Börse
Anzahl
Aktueller Kurs
Kurszeit
Kaufpreis
Kaufdatum
Kaufwert	CHF
	Hinzufügen Speichern

UBS Group	27.65	2.14 %	K V
Novartis	88.82	1.30 %	K V
Part Grp Hldg	1’233.00	1.23 %	K V
Kuehne+Nagel Int	207.50	1.22 %	K V
Lonza Grp	538.00	1.05 %	K V
Swisscom	503.00	0.40 %	K V
Sonova Hldg	296.60	0.34 %	K V
Swiss Life Hldg	697.40	0.11 %	K V
Zurich Insur Gr	539.60	0.11 %	K V
Holcim	87.40	0.02 %	K V

Nachrichten zu Valeant Pharmaceuticals International Inc.

Aktien Top/Flop

Meistgelesene Nachrichten